AMPLI-PPHI, led by Michael Muthamia, aims to reduce maternal mortality and morbidity by promoting the adoption of new PPH prevention and treatment drugs. The program focuses on heat-stable carbetocin, tranexamic acid, and misoprostol, aiming to overcome supply-side barriers and shape markets. Target

1 views • 13 slides

Presented by Michael Muthamia, the AMPLI-PPHI program aims to reduce maternal mortality by promoting the early adoption and scale-up of new PPH treatments. With a focus on heat-stable carbetocin, tranexamic acid, and misoprostol, the program drives catalytic change through evidence generation, marke

2 views • 13 slides

Abortion practices in Laos have evolved from historical unsafe methods to the introduction of safer options like Misoprostol. The past involved dangerous techniques leading to complications, pushing women towards unsafe abortions, including the illegal use of Ya Chine. With the registration of Misop

0 views • 15 slides

Induction of labor is done to achieve vaginal delivery before spontaneous onset, usually at 39 weeks or when medically necessary. Risks include failed induction, cesarean section, uterine rupture, prolonged labor, and infections. Cervical ripening methods help prepare the cervix for labor. The Bisho

0 views • 18 slides

Second trimester miscarriage, occurring after 12 weeks of gestation, can be caused by factors such as cervical injury, infections, thrombophilias, uterine abnormalities, and chromosomal issues. Management options include medical, surgical, and expectant approaches, with factors like gestational age

1 views • 16 slides